Literature DB >> 21707399

Computational tools for polypharmacology and repurposing.

Janosch Achenbach1, Pekka Tiikkainen, Lutz Franke, Ewgenij Proschak.   

Abstract

Most drugs act on a multitude of targets rather than on one single target. Polypharmacology, an upcoming branch of pharmaceutical science, deals with the recognition of these off-target activities of small chemical compounds. Due to the high amount of data to be processed, application of computational methods is indispensable in this area. This review summarizes the most important in silico approaches for polypharmacology. The described methods comprise network pharmacology, machine learning techniques and chemogenomic approaches. The use of these methods for drug repurposing as a branch of drug discovery and development is discussed. Furthermore, a broad range of prospective applications is summarized to give the reader an overview of possibilities and limitations of the described techniques.

Mesh:

Substances:

Year:  2011        PMID: 21707399     DOI: 10.4155/fmc.11.62

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  13 in total

1.  Computer-Aided Selective Optimization of Side Activities of Talinolol.

Authors:  Kerstin Hiesinger; Jan S Kramer; Janosch Achenbach; Daniel Moser; Julia Weber; Sandra K Wittmann; Christophe Morisseau; Carlo Angioni; Gerd Geisslinger; Astrid S Kahnt; Astrid Kaiser; Anna Proschak; Dieter Steinhilber; Denys Pogoryelov; Karen Wagner; Bruce D Hammock; Ewgenij Proschak
Journal:  ACS Med Chem Lett       Date:  2019-05-29       Impact factor: 4.345

Review 2.  The emerging paradigm of network medicine in the study of human disease.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

Review 3.  Systems psychopharmacology: A network approach to developing novel therapies.

Authors:  Peter J Gebicke-Haerter
Journal:  World J Psychiatry       Date:  2016-03-22

Review 4.  Polypharmacology: drug discovery for the future.

Authors:  A Srinivas Reddy; Shuxing Zhang
Journal:  Expert Rev Clin Pharmacol       Date:  2013-01       Impact factor: 5.045

5.  Improved prediction of drug-target interactions using regularized least squares integrating with kernel fusion technique.

Authors:  Ming Hao; Yanli Wang; Stephen H Bryant
Journal:  Anal Chim Acta       Date:  2016-01-14       Impact factor: 6.558

6.  The virtue of innovation: innovation through the lenses of biological evolution.

Authors:  Douglas B Kell; Elena Lurie-Luke
Journal:  J R Soc Interface       Date:  2015-02-06       Impact factor: 4.118

7.  Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules.

Authors:  Michael Reutlinger; Christian P Koch; Daniel Reker; Nickolay Todoroff; Petra Schneider; Tiago Rodrigues; Gisbert Schneider
Journal:  Mol Inform       Date:  2013-02-07       Impact factor: 3.353

8.  Curation and analysis of multitargeting agents for polypharmacological modeling.

Authors:  A Srinivas Reddy; Zhi Tan; Shuxing Zhang
Journal:  J Chem Inf Model       Date:  2014-08-29       Impact factor: 4.956

Review 9.  Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Authors:  Vinayak Palve; Yi Liao; Lily L Remsing Rix; Uwe Rix
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

10.  Navigating traditional chinese medicine network pharmacology and computational tools.

Authors:  Ming Yang; Jia-Lei Chen; Li-Wen Xu; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.